A randomized-controlled trial of AST-OPC1 in patients with Spinal-cord-injuries

Trial Profile

A randomized-controlled trial of AST-OPC1 in patients with Spinal-cord-injuries

Planning
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2018

At a glance

  • Drugs OPC 1 (Primary)
  • Indications Spinal cord injuries
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Jul 2018 According to an Asterias Biotherapeutics media release, the company expects to submit an application to the California Institute of Regenerative Medicine (CIRM) to apply for funding to support this study.
    • 09 Feb 2017 According to an Asterias Biotherapeutics media release, company expect to commence this trial in early 2018.
    • 09 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top